Filter posts

Patent Evergreening in India: Response from the Other Side

Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in …

Patent "Ever-Greening": Novartis Confronts Patent Myth in India

India’s ‘increased efficacy’ patentability requirement for medicines prevents an improved form of a known drug …

Scientific American on BRIC's IP Environment

Scientific American World View issued a special report at this year’s 2011 BIO International Convention …